Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis
Status:
Withdrawn
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of four doses of PRO-118
ophthalmic solution ophthalmic solution compared with placebo, for the treatment of seasonal
(SAC) and perennial (PAC) allergic conjunctivitis.